TECHBio-Techne Corp

Are SYNA, IRDM, TECH, PATK Obtaining Fair Deals for their Shareholders? Are SYNA, IRDM, TECH, PATK Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 2, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--FSRL, SYNA, TECH, and NDRA SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--FSRL, SYNA, TECH, and NDRA PR Newswire NEW YORK, July 2, 2026 NEW YORK, July 2, 2026 /PRNewswire/ -- Class...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Bio-Techne Corporation (NasdaqGS: TECH) to Merck KGaA. Under the terms of the proposed transaction, shareholders of Bio-Techne will receive $73.00...

Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders? Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 29, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Bio-Techne Corporation (NASDAQ: TECH) SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Bio-Techne Corporation (NASDAQ: TECH) PR Newswire NEW YORK, June 26, 2026 NEW YORK, June 26, 2026 /PRNewswire...

Companies in The News Are: BB, MKC, META, TECH, MKKGY

Bio-Techne (NASDAQ:TECH), a life science reagents, instruments, and bioprocessing tools provider, closed at $70.67, up 20.02%. Merck KGaA's $73-per-share cash offer drove the move, and investors are watching the deal timetable and any updates on closing conditions. Trading volume...

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion...